% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • rybovich58 rybovich58 Jan 26, 2012 11:50 AM Flag

    Not "a final decision"

    The court’s action would let Amphastar and Watson enter the market for generic Lovenox, Michael Tong, an analyst with Wells Fargo Securities in New York, said in a note to clients. Parsippany, New Jersey-based Watson would have to begin sales knowing there’s a risk it could later lose the case, Tong said.

    “A launch is not necessarily imminent,” he said.

    Momenta and Novartis AG (NOVN)’s Sandoz unit already sell a copy of Lovenox, and Momenta won an order in October that prevented Amphastar and Watson from marketing their version. The appeal of that decision was heard by on Jan. 24. The resulting “order does not represent a final decision with respect to the merits of the pending appeal,” the court said in yesterday’s docket.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.530.00(0.00%)Oct 26 4:00 PMEDT